Dataset Open Access

Quantification of E-cadherin Expression in H1299 NSD3 Knockdown Cells

Dilworth, David; Barsyte-Lovejoy, Dalia

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="" xmlns:oai_dc="" xmlns:xsi="" xsi:schemaLocation="">
  <dc:creator>Dilworth, David</dc:creator>
  <dc:creator>Barsyte-Lovejoy, Dalia</dc:creator>
  <dc:description>SGC Open Notebook Project to Characterize the HMTase NSD3

Exp023 Objective: Having observed downregulation of E-cadherin protein levels in response to NSD3 overexpression in H1299 cells (exp021), I was next interested in testing the consequences of NSD3 knockdown. To do so, I transfected H1299 cells with siRNA targeting NSD3, both short and long isoforms, and assayed E-cadherin expression by western blotting.  </dc:description>
  <dc:description>Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.</dc:description>
  <dc:title>Quantification of E-cadherin Expression in H1299 NSD3 Knockdown Cells</dc:title>
All versions This version
Views 14897
Downloads 9854
Data volume 208.1 MB115.0 MB
Unique views 11080
Unique downloads 7042


Cite as